FindTrial
Sign In

Chnages in the placenta due to COVID 19 infection during pregnancy

Placental changes in relation to SARS-Cov2 infection in pregnancy - PRSAP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038318
Enrollment
118
Registered
2021-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: U071- COVID 19 virus identified

Interventions

None listed

Sponsors

MOSC Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All mothers who were found to be Covid positive anytime during pregnancy 2. Mothers consenting to send their placenta for histopathological examination

Exclusion criteria

Exclusion criteria: 1. History of other viral infections during pregnancy 2. Mothers diagnosed with preeclampsia or gestational hypertension or IUGR before the COVID infection 3. Those with pregestational diabetes, chronic hypertension and a history of thrombophilia.

Design outcomes

Primary

MeasureTime frame
presence of maternal fetal vascular malperfusion in the placenta Timepoint: at delivery—

Secondary

MeasureTime frame
maternal complicationsTimepoint: 21 days of infection at delivery;Neonatal complicationsTimepoint: 7 days of age—

Countries

India

Contacts

Public ContactAnu Anna George

MOSC Medical College Hospital

annamed013@gmail.com09539748095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026